2008
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
Search citation statements
Paper Sections
Select...
58
4
2
2
Citation Types
0
24
0
2
Year Published
Range
2009
2025
Publication Types
Select...
58
3
3
Relationship
1
63
Authors
Journals
Cited by 63 publications
(26 citation statements)
References 37 publications
0
24
0
2
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The rate was higher despite the start of immunomodulatory treatment in 26.6% of our children with isolated ON. Such treatment was shown to decrease the rate of conversion to MS in adults with CIS and may have biased our results toward less MS cases compared to a natural history cohort . The use of more sensitive diagnostic criteria for MS in our cohort and a potential selection bias for MS versus non‐MS patients by an allowed shorter minimum follow‐up period for future MS patients may partially explain the difference to previous studies.…”
Section: Discussion
mentioning
confidence: 80%